Verizon 2026 stock analysis: Frontier Communications acquisition debt impact, C-band 5G build, postpaid turnaround, and whether the 6% dividend yield is genuinely safe.
Merck (MRK) 2026 stock analysis: Keytruda's 2028 patent cliff, Winrevair growth, $112.30 price, 3% dividend, analyst targets, and US investor tax strategy.
AT&T stock analysis for 2026: post-WarnerMedia FCF recovery, 5G fiber expansion, debt deleveraging, and whether the $1.11 dividend can hold. Analyst target $30.53.
Pfizer (PFE) 2026 stock analysis: $26.48 price, 6.5% dividend yield, Seagen pipeline, patent cliff risks, and 12-month price targets for US investors.
Set up DRIP at Schwab, Fidelity, or Vanguard. Covers fractional reinvestment, tax implications, and a 30-year simulation showing the power of compounding.
Samsung preferred (005935) trades at a 25% discount to common. Covers access from abroad, dividend yield premium, KRX hours, and withholding tax.